Genoptix Announces Participation at the 2008 Southern California Investor Conference

Genoptix Announces Participation at the 2008 Southern California Investor
Conference

CARLSBAD, Calif., Aug. 27 /PRNewswire-FirstCall/ -- Genoptix, Inc.
(Nasdaq: GXDX), a specialized laboratory services provider, today announced
the Company's participation at the 2008 Southern California Investor
Conference scheduled to take place at The Islands Hotel in Newport Beach, CA
on September 3, 2008.
Sam Riccitelli, Executive Vice President and COO of Genoptix, will present
at the conference on that Wednesday, beginning at approximately 8:30 am, PDT.
Mr. Riccitelli will provide an overview of the Company's specialized
diagnostic laboratory service offerings, growth strategies and past
operational performance.
The presentation is expected to last approximately 20 minutes, followed by
a short question and answer session, all of which will be web cast live on the
Internet and accessible through the investor relations section of the Genoptix
website at http://www.genoptix.com. Those who would like to listen to the
presentation should go to this site at least 15 minutes prior to the event to
register, download and install any necessary software. A replay will also be
available for 30 days following the initial presentation web cast.
About Genoptix, Inc.
Genoptix is a specialized laboratory service provider focused on
delivering personalized and comprehensive diagnostic services to
community-based hematologists and oncologists. Genoptix is headquartered in
Carlsbad, California.
Forward-Looking Statements
This press release contains forward-looking statements that are subject to
risks and uncertainties that could cause actual results to differ materially
from those set forth in the forward-looking statements. Genoptix disclaims,
however, any intent or obligation to update these forward-looking statements.
SOURCE Genoptix, Inc.

Marcy Graham, Sr. Director, Investor Relations of Genoptix, Inc.,
+1-760-930-7150, investorrelations@genoptix.com; or Joleen Schultz, Principal
of Mentus, +1-858-455-5500, ext. 215, jschultz@mentus.com, for Genoptix, Inc.